Deterioration of asthma in a patient with diffuse panbronchiolitis (DPB) after macrolide therapy

Journal of Asthma

Volumn 47, Issue 4, 2010, Pages 486-488

  Matsuno, Osamu ^a   Ueno, Kiyonobu ^a   Hayama, Yoshitomo ^a   Honda, Hidehiro ^a   Yamane, Hiroyuki ^a   Saeki, Yukihiko ^a  

^a MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Asthma; Diffuse panbronchiolitis; Macrolide therapy

Indexed keywords

BUDESONIDE; CLARITHROMYCIN; PROCATEROL;

ADULT; ARTICLE; ASTHMA; BRONCHIOLITIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DRUG RESPONSE; FEMALE; HUMAN; LOW DRUG DOSE; LUNG BIOPSY; LUNG FUNCTION; MEDICAL HISTORY; SYMPTOM; THORAX RADIOGRAPHY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHIOLITIS; CLARITHROMYCIN; FEMALE; HUMANS; MACROLIDES; PROCATEROL; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953327109     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770901003759444     Document Type: Article

References (14)

1. Homma H, Yamanaka A, Tanimoo S., Tamura M, Chijimatsu Y, Kira S, Izumi T. Diffuse panbronchitis: a disease of the transitional zone of the lung. Chest 1983; 83:27-69.
2. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157:1829-1832.
3. Takayanagi N, Kanazawa M, Kawabata Y, Colby TV. Chronic bronchiolitis with associated eosinophilic lung disease (eosinophilic bronchiolitis). Respiration 2001; 68: 319-322.
4. Fukushima Y, Kamiya K, Tatewaki M, Fukushima F, Hirata H, Ishii Y, Fukuda T. A patient with bronchial asthma in whom eosinophilic bronchitis and bronchiolitis developed during treatment. Allergol Int 2010; 59: 87-91.
5. Ogawa H, Fujimura M, Matsuda T, Nakamura H, Kumabashiri I, Kitagawa S. Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia. Chest. 1993; 104:493-496.
6. Kobayashi H, Matsubara O, Kano S, Uwabe Y, Kikuma H, Morisako T, Aida S, Tamai S, Nagata N. [Clinico-pathological analysis of airway abnormalities in patients with chronic eosinophilic pneumonia]. Nihon Kyobu Shikkan Gakkai Zasshi 1996; 34:1343-1348 [Japanese with English abstract].
7. Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Human Pathol 1985; 16:700-706.
8. Azuma A, Kudoh S. Diffuse panbronchiolitis in East Asia. Respirology 2006; 11:249-261.
9. Poletti V, Casoni G, Chilosi M, Zompatori M. Diffuse panbronchiolitis. Eur Respir J 2006 ; 28:862-871.
10. Hatipoglu U, Rubinstein I. Low-dose, long-term macrolide therapy in asthma: an overview. Clin Mol Allergy 2004; 16.
11. Crosbie PAJ, Woodhead MA. Long-term macrolide therapy in chronic inflammatory airway disease. Eur Respir J 2009; 33:171-181.
12. Amayasu H, Yoshida S, Ebana S, Yamamoto Y, Nishikawa T, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Ishizaki Y. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000; 84:594-598.
13. Koyama H, Nishimura K, Mio T, Ikeda A, Sugiura N, Izumi T. Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis. Thorax 1994; 49: 540-544.
14. Park SJ, Lee YC, Rhee YK, Lee HB. The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis. Biochem Biophys Res Commun 2004; 324:114-117.